Jump to content
Meds TB-500

A precise, evidence-first readout of the TB-500 (Ac-LKKTETQ) and thymosin beta-4 research literature - what the studies establish, where the human data stop, and how compounded access actually stands.

A study amount belongs to the treatment and animals tested

TB-500 dosage cannot be set from the available study amounts.

The shorter chain was made to keep the protein part involved in moving cells toward injuries. Researchers mostly tested amounts of thymosin beta-4, leaving a safe amount of the copied chain unestablished for you.

TB-500 dosage lacks human proof of a safe treatment amount

Your treatment has no TB-500 dosage established by human comparison trials. A finished study comparing the shorter chain with other care is still missing [5].

Most studies of amounts gave thymosin beta-4 to animals or healthy volunteers [5]. The amount can't be understood apart from the substance and where treatment was given.

TB-500 lacks protein parts that may affect how repair happens. You can't establish a treatment amount from the longer protein's findings.

Treatment with 2 and 12 milligrams per kilogram improved recovery in rats after stroke [4]. Rats receiving 18 milligrams per kilogram showed no clear recovery gain.

That experiment found no clear help from giving the largest tested amount. Users share self-treatment plans, without human trials checking those plans for you [5].

Different groups received different amounts of the longer protein

Rodent heart and brain tests used about 6-12 milligrams per kilogram, adjusted to the animal’s weight. Thymosin beta-4 stroke tests used 2-18 milligrams per kilogram, with each amount adjusted for the rat's weight [4].

Mice received 150 micrograms twice weekly for 6 months around their belly organs [9]. A gram contains a million micrograms; those mice received thymosin beta-4.

The early human safety test, Phase 1, gave thymosin beta-4 directly into a vein. Separate groups tested separate amounts: 42, 140, 420, and 1260 milligrams.

Each group received an initial treatment, then daily treatment for 14 days [6]. No volunteer received all the listed amounts; each group tested its own amount.

In dishes, 10 picograms made skin cells move; a gram contains a trillion picograms. Small amounts also produced changes in cells near hair roots, leaving your treatment amount unanswered [3][5].

Different groups received different amounts of the longer protein

Shots, vein treatment, and surface treatment answer different questions

Many rodents received shots inside the belly, into the space surrounding their organs [3][4][9]. The medicine passed beyond skin and muscle rather than being left in those tissues.

For the early human safety test, Phase 1, researchers gave thymosin beta-4 through a vein [6]. Researchers applied thymosin beta-4 to damaged skin or eyes in other experiments [5][12].

People trying research supplies describe putting shots beneath skin or within muscle. These are users' reports, without a comparison trial checking healing or safety for you [5].

TB-500 half-life has not been measured in human blood

A half-life is the time until half a measured amount leaves the blood [5]. Researchers haven't established that clearing time for TB-500 in people.

The Phase 1 early safety study found larger thymosin beta-4 amounts left blood more slowly [6]. You can't apply that clearing time to another substance given in another way.

Horse sports tests seek traces of TB-500 and pieces remaining after the chain breaks down [5]. Finding traces of prohibited use in a horse's blood or urine doesn't measure clearing from your blood.

The missing human measurement leaves no reliable clearing time for the shorter chain. You still lack that measurement after the longer protein's tests.

Careful storage does not establish a safe plan for self-treatment

People trying TB-500 research supplies share plans that start high and later reduce amounts. Those plans lack human comparison tests showing safety or benefit for you [5].

The highest amount failed to produce the clearest stroke recovery in rats [4]. The belief that more treatment always improves healing doesn't fit that finding.

Laboratory workers add sterile water, which is germ-free, or water that limits germ growth. The dried chain withstands storage better than the longer protein, but still needs cold storage.

The contents may spoil after several rounds of freezing and thawing despite that greater stability [5]. A well-kept bottle still can't establish safety or a healing benefit for you.